Billing Beat

Aetna – New Pre-approval Requirements for Alabama, Arkansas, Louisiana and Mississippi Commercial Members

January 6, 2022

Our Enhanced Clinical Review program with eviCore healthcare will require pre-approval for certain procedures. The program will start on November 1, 2021. It affects Alabama, Arkansas, Louisiana, and Mississippi members in our fully insured and self-insured commercial HMO/PPO Aetna® products.

Services that require pre-approval:

  • High-tech outpatient diagnostic imaging procedures such as MRI/MRA, nuclear cardiology, and PET scan and CT scan, including CTA
  • Nonemergent outpatient stress echocardiography
  • Nonemergent outpatient diagnostic left and right heart catheterization
  • Insertion, removal and upgrade of elective implantable cardioverter defibrillator, cardiac resynchronization therapy defibrillator and implantable pacemaker
  • Polysomnography (attended sleep studies)
  • Interventional pain management
  • Radiation therapy services (for fully insured members only) — these include complex and 3D conformal; Stereotactic Radiosurgery (SRS)/Stereotactic Body Radiation Therapy (SBRT); brachytherapy; hyperthermia; Intensity-Modulated Radiation Therapy (IMRT)/Image Guided Radiation Therapy (IGRT); proton beam therapy; neutron beam therapy; and radiopharmaceuticals

The source page for this article has moved or has expired.

Please visit the Billing Beat News or Beyond Billing Blog for relevant information or search our site for specific information related to this article.

Original source URL:
https://www.aetna.com/content/dam/aetna/pdfs/olu/officelink-updates-dec-2021-olu.pdf

Sign up for Billing Beat